Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydro-azepinoquinolines as agonists of the 5-HT2C receptor

Tetrahydro-azepinoquinolines as agonists of the 5-HT2C receptor

US Patent 10131660 · Granted Nov 20, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bruton's tyrosine kinase inhibitors2025
Bruton's tyrosine kinase inhibitors2024
Bruton's tyrosine kinase inhibitors2024
Compositions and methods for treating human papilloma virus infections2024
Small molecule antiviral drug treatment for human papillomavirus infections2024
Small molecule antiviral drug treatment for human papillomavirus infections2023
Bruton's tyrosine kinase inhibitors2023
Bruton's tyrosine kinase inhibitors2023
6-mercaptopurine nucleoside analogues2022
JAK inhibitors2022
Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteri2021
Bruton's tyrosine kinase inhibitors2021